Supernus announces Feb 27 earnings release date for Q4 and FY 2023

SUPERNUS PHARMACEUTICALS, INC.

Earnings release for Q4 and full year 2023 expected after market close on February 27, 2024.
Conference call at 4:30 PM ET on Feb 27 with CEO Jack Khattar and CFO Tim Dec.
No preliminary financial results disclosed; only schedule details provided in this filing.
Webcast and replay available on investor relations website for 60 days.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.7

SUPERNUS PHARMACEUTICALS, INC. reported financial results for the fourth quarter and full year of 2023.

Period: the fourth quarter and full year of 2023
Result: reported results

Exact text from the filing

Supernus Pharmaceuticals, Inc. issued a press release announcing that it expects to report its business results for the fourth quarter and full year of 2023 after the market closes on Tuesday, February 27, 2024.

View on SEC.gov

Browse all earnings releases →

SUPERNUS PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001356576-24-000006

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.